- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05422729
mHealth-supported Coach
A Multidisciplinary-led Personalised mHealth-supported Coach for Reducing Midlife Stroke Risk
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Aim: To evaluate the effects of a personalised mHealth-supported coach programme on the adoption of health-promoting behaviours in the middle-aged group, in comparison with usual care.
Design: A 24-month prospective two-arm, parallel-group, single-blinded, repeated-measure randomised controlled trial will be conducted.
Participants: People who aged between 40 and 64, mentally competent, have a non-laboratory INTERHEART risk score (IHRS) of 10 or higher, communicable in Chinese and free from stroke and transient ischemic attack (TIA) or other cardiovascular disease will be eligible to the study. A total of 164 participants will be recruited through a district community centre and randomly assigned on 1:1 ratio to the intervention group or the control group.
Intervention: A theory-based mHealth-supported coach programme, including individual consultation sessions and a mobile application with a virtual sharing platform, is developed by a multidisciplinary team for the intervention group over three months, whereas the control group receives usual care.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Helen Y Chan, Ph.D
- Phone Number: +85239438099
- Email: helencyl@cuhk.edu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong, 00000
- Recruiting
- The Chinese University of Hong Kong
-
Contact:
- Helen Chan
- Phone Number: 39438099
- Email: helencyl@cuhk.edu.hk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Chinese ethnic
- able to read Chinese and communicate in Cantonese/Mandarin
- with non-laboratory IHRS score 10 or higher
Exclusion Criteria:
- mentally incompetent
- previously diagnosed with stroke, TIA, MI, coronary heart disease, heart failure or atrial fibrillation
- with eye or retinal disease
- with terminal disease with an expected life expectancy less than six months
- being pregnant
- have enrolled in other lifestyle-based or exercise-based projects
- do have mobile devices or internet service to access the mobile application
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Personalised mHeatlh-supported coaching programme
Three monthly individual consultation session, supported with a specific mobile application.
|
The intervention includes two components.
Three individual consultation sessions based on a health coaching protocol developed by a multidisciplinary team.
A mobile application provides educational information about healthy lifestyles, knowledge quizzes, telemonitoring function and virtual platform for sharing.
|
Active Comparator: Traditional in-person health coaching programme
Three monthly individual consultation sessions.
|
Three individual consultation sessions delivered by a nurse.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Health-promoting behaviours
Time Frame: 3-month post-allocation
|
Four subscales, including health responsibility, nutrition, physical activity and stress management, of the Health Promoting Lifestyle Profile II.
The possible score range from 34 to 136, with a higher score meaning healthier lifestyles were adopted.
|
3-month post-allocation
|
Health-promoting behaviours
Time Frame: 6-month post-allocation
|
Four subscales, including health responsibility, nutrition, physical activity and stress management, of the Health Promoting Lifestyle Profile II.
The possible score range from 34 to 136, with a higher score meaning healthier lifestyles were adopted.
|
6-month post-allocation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-efficacy of adopting health-promoting behaviours
Time Frame: 3-month post-allocation
|
The adapted version of the Diabetes Mellitus Type II Self Efficacy Scale will be used.
Participants will rate their level of confidence in various behaviours, in diet control, weight control and lifestyle management, by using a five-point Likert scale.
The possible scores ranged from 7 to 35, with a higher score meaning a higher level of self-efficacy.
|
3-month post-allocation
|
Self-efficacy
Time Frame: 6-month post-allocation
|
The adapted version of the Diabetes Mellitus Type II Self Efficacy Scale will be used.
Participants will rate their level of confidence in various behaviours, in diet control, weight control and lifestyle management, by using a five-point Likert scale.
The possible scores ranged from 7 to 35, with a higher score meaning a higher level of self-efficacy.
|
6-month post-allocation
|
INTERHEART risk score
Time Frame: 3-month post-allocation
|
The score was calculated based on the weighted sum of nine risk factors, including age, sex, lifestyles and psychosocial wellbeing, which were significantly related to cardiovasuclar diseases.
The possible score range was 0 - 48, in which a higher score corresponds to higher risk.
|
3-month post-allocation
|
INTERHEART risk score
Time Frame: 6-month post-allocation
|
The score was calculated based on the weighted sum of nine risk factors, including age, sex, lifestyles and psychosocial wellbeing, which were significantly related to cardiovasuclar diseases.
The possible score range was 0 - 48, in which a higher score corresponds to higher risk.
|
6-month post-allocation
|
automatic retinal image analysis
Time Frame: 3-month post-allocation
|
Retinal fundus image will be obtained from both eyes of the participant using a non-mydriatic digital retinal camera (Canon CR-2 AF, U.S.A., Inc).
Stroke risk estimation will be determined through fractural analysis, statistical texture analysis and high-order spectra analysis based on the retinal vessel parameters.
The ARIA-stroke algorithm developed using R and Matlab software has a sensitivity and a specificity of 94.7% and 100%, respectively.
The value between 0.5 and 0.7 is considered as moderate risk, while high risk is considered at 0.7 or higher.
|
3-month post-allocation
|
automatic retinal image analysis (ARIA)
Time Frame: 6-month post-allocation
|
Retinal fundus image will be obtained from both eyes of the participant using a non-mydriatic digital retinal camera (Canon CR-2 AF, U.S.A., Inc).
Stroke risk estimation will be determined through fractural analysis, statistical texture analysis and high-order spectra analysis based on the retinal vessel parameters.
The ARIA-stroke algorithm developed using R and Matlab software has a sensitivity and a specificity of 94.7% and 100%, respectively.
The value between 0.5 and 0.7 is considered as moderate risk, while high risk is considered at 0.7 or higher.
|
6-month post-allocation
|
Psychological distress
Time Frame: 3-month post-allocation
|
The Depression Anxiety Stress Scale (DASS-21)includes 21 items, with 7 in each subscale: depression, anxiety and stress.
Participants will rate their level of agreement with the statements on a 4-point Likert scale, from 0 (not apply to me at all) to 3 (applied to me very much).
The potential scores range from 0 to 63, with a higher score means higher level of distress experienced.
|
3-month post-allocation
|
Psychological distress
Time Frame: 6-month post-allocation
|
The Depression Anxiety Stress Scale (DASS-21)includes 21 items, with 7 in each subscale: depression, anxiety and stress.
Participants will rate their level of agreement with the statements on a 4-point Likert scale, from 0 (not apply to me at all) to 3 (applied to me very much).
The potential scores range from 0 to 63, with a higher score means higher level of distress experienced.
|
6-month post-allocation
|
Change in Blood pressure
Time Frame: Between baseline and 3-month post-allocation
|
Blood pressure measurement will be carried out, after 10 min of rest, on the left arm in a sitting posture by using an electronic sphygmomanometer.
|
Between baseline and 3-month post-allocation
|
Change in Blood pressure
Time Frame: Between 3-month and 6-month post-allocation
|
Blood pressure measurement will be carried out, after 10 min of rest, on the left arm in a sitting posture by using an electronic sphygmomanometer.
|
Between 3-month and 6-month post-allocation
|
Change in Body mass index (BMI)
Time Frame: Between baseline and 3-month post-allocation
|
BMI will be calculated by dividing the weight (in kilogram) by the height (in meter) squared.
The height will be measured using a stadiometer, and body weight will be measured using an electronic scale.
|
Between baseline and 3-month post-allocation
|
Change in Body mass index(BMI)
Time Frame: Between 3-month and 6-month post-allocation
|
BMI will be calculated by dividing the weight (in kilogram) by the height (in meter) squared.
The height will be measured using a stadiometer, and body weight will be measured using an electronic scale.
|
Between 3-month and 6-month post-allocation
|
Change in Waist-hip ratio (WHR)
Time Frame: Between baseline and 3-month post-allocation
|
WHR will be used for determining body fat distribution.
Waist circumference will be measured at the mid-point between the lowest rib and the iliac crest, whereas hip circumference will be measured at the widest level over the great trochanters.
The two measurements will be measured to the nearest 0.1 cm by using a measuring tape.
|
Between baseline and 3-month post-allocation
|
Change in Waist-hip ratio (WHR)
Time Frame: Between 3-month and 6-month post-allocation
|
WHR will be used for determining body fat distribution.
Waist circumference will be measured at the mid-point between the lowest rib and the iliac crest, whereas hip circumference will be measured at the widest level over the great trochanters.
The two measurements will be measured to the nearest 0.1 cm by using a measuring tape.
|
Between 3-month and 6-month post-allocation
|
Change in Fasting blood glucose
Time Frame: Between baseline and 3-month post-allocation
|
Blood samples will be taken by an experienced nurse and sent to accredited commercial biochemistry laboratories for analysis.
|
Between baseline and 3-month post-allocation
|
Change in Fasting blood glucose
Time Frame: Between 3-month and 6-month post-allocation
|
Blood samples will be taken by an experienced nurse and sent to accredited commercial biochemistry laboratories for analysis.
|
Between 3-month and 6-month post-allocation
|
Change in Blood lipid profile
Time Frame: Between baseline and 3-month post-allocation
|
The profile includes ncluding triglyceride, total Cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C).
Blood samples will be taken by an experienced nurse and sent to accredited commercial biochemistry laboratories for analysis.
|
Between baseline and 3-month post-allocation
|
Change in Blood lipid profile
Time Frame: Between 3-month and 6-month post-allocation
|
The profile includes ncluding triglyceride, total Cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C).
Blood samples will be taken by an experienced nurse and sent to accredited commercial biochemistry laboratories for analysis.
|
Between 3-month and 6-month post-allocation
|
Collaborators and Investigators
Investigators
- Principal Investigator: Helen Y Chan, Ph.D, Chinese University of Hong Kong
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 05200218
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Disease Risk Factors
-
The University of Texas at ArlingtonAmerican Heart AssociationRecruitingCardiovascular Diseases | Heart Disease Risk FactorsUnited States
-
University of RochesterCompletedLow Risk (0-10% Chance) of Developing Cardiovascular Disease Within 10 Years Based on Risk Factors | Moderate Risk (10-20% Chance) of Developing Cardiovascular (Heart) Disease Within 10 Years Based on Risk FactorsUnited States
-
University Hospital, BordeauxCompletedCardiovascular Disease Risk FactorsFrance
-
Penn State UniversityOcean Spray Cranberries, Inc.CompletedCardiovascular Disease Risk FactorsUnited States
-
The University of Hong KongHealth and Medical Research FundCompleted
-
Mayo ClinicCompletedCardiovascular Disease Risk FactorsUnited States
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Foundation for Science, Health and Education, SpainHospital del Mar Research Institute (IMIM); La Caixa FoundationEnrolling by invitationHealth Behavior | Healthy Lifestyle | Heart Disease Risk FactorsSpain
-
Kaiser PermanenteAgency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular Disease (CVD) Risk FactorsUnited States
-
University of NebraskaCompletedCardiovascular Risk FactorsUnited States
Clinical Trials on mHealth-supported coaching
-
Ohio State UniversityActive, not recruitingKidney Transplant; Complications | Kidney TransplantUnited States
-
University of PittsburghNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...UnknownHeart Transplant
-
Duke UniversityVanderbilt UniversityCompletedHigh Intensity Interval Training | Critical Illness | Covid19 | Fitness Trackers | ICU | Intensive Care UnitsUnited States
-
Boston UniversityCompletedHypertensionUnited States
-
NYU Langone HealthWeizmann Institute of Science; American Heart AssociationCompletedOverweight and Obesity | Pre-diabetesUnited States
-
University of ConnecticutNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Recruiting
-
German Diabetes CenterCompletedType 2 Diabetes | Fatty Liver, NonalcoholicGermany
-
Liverpool John Moores UniversityLiverpool Heart and Chest Hospital NHS Foundation Trust; University Hospitals... and other collaboratorsRecruiting
-
Duke UniversityNot yet recruitingAlcohol Drinking | Suicide